Baseline methotrexate does not impact the incidence of infliximab infusion reactions: Results from a Canadian real-world treatment registry

被引：0
|
作者：
Gulliver, Wayne [1 ]
Nantel, Francois [2 ]
Winkelman, Warren [2 ]
机构：
[1] Mem Univ Newfoundland, St John, NF, Canada
[2] Merck Canada Inc, Kirkland, PQ, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2012年 / 66卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB171 / AB171
页数：1
相关论文
共 50 条
  • [1] FACTORS ASSOCIATED WITH THE INCIDENCE OF INFUSION REACTIONS TO INFLIXIMAB: RESULTS FROM "REMITRAC INFUSION", A PROSPECTIVE REAL-WORLD COMMUNITY REGISTRY
    Choquette, D.
    Bensen, W. J.
    Faraawi, R.
    Nantel, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 932 - 932
  • [2] Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry
    Choquette, Denis
    Faraawi, Rafat
    Chow, Andrew
    Rodrigues, Jude
    Bensen, William J.
    Nantel, Francois
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1105 - 1111
  • [3] Incidence of Infusion Reactions to Intravenous Golimumab: Results from a Prospective, Real-World Community Registry
    Faraawi, Rafat
    Chow, Andrew
    Khraishi, Majed
    Haaland, Derek
    Baker, Milton
    Tkaczyk, Cathy
    Lehman, Allen
    Nantel, Francois
    Osborne, Brendan
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1034 - 1034
  • [4] Incidence of infusion reactions to intravenous golimumab: results from a prospective, real-world community registry
    Faraawi, R.
    Chow, A.
    Khraishi, M.
    Haaland, D.
    Nantel, F.
    Osborne, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) : 371 - 371
  • [5] Incidence of Infusion Reactions to Intravenous Golimumab: Results from a Prospective, Real-World Community Registry
    Faraawi, Rafat
    Chow, Andrew
    Khraishi, Majed M. M.
    Haaland, Derek
    Baker, Milton F.
    Tkaczyk, Cathy
    Lehman, Allen J.
    Nantel, Francois
    Osborne, Brendan
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] What are the Implications of Concomitant and Premedication on Infusion Reactions to Infliximab: Results from "RemiTRAC Infusion", a Prospective Real-World Community Registry
    Choquette, Denis
    Faraawi, Rafat
    Njoya, Merlin
    Got, Tiffany
    Bensen, William
    Nantel, Francois
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1451 - 1451
  • [7] What Are The Implications Of Concomitant and Pre-Medication On Infusion Reactions To Infliximab: Results From "RemiTRAC Infusion", a Prospective Real-World Community Registry.
    Choquette, Denis
    Faraawi, Rafat Y.
    Njoya, Merlin
    Chow, Andrew
    Bensen, William G.
    Nantel, Francois
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S197 - S197
  • [8] Methotrexate Use At Infliximab Initiation and Impact On Treatment Outcomes: An Analysis From A Canadian Registry
    Choquette, Denis
    Thorne, J. Carter
    Kelsall, John T.
    Zummer, Michel
    Starr, Michael
    Sheriff, Maqbool K.
    Bensen, William G.
    Chow, Andrew
    Baer, Philip
    Rampakakis, Emmanouil
    Sampalis, John S.
    Nantel, Francois
    Lehman, Allen J.
    Otawa, Susan M.
    Shawi, May
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S211 - S212
  • [9] Safety of Infliximab Treatment in a Real-World Clinical Setting: Description and Evaluation of Infusion Reactions
    Kelsall, John
    De Vera, Mary
    Rogers, Pamela
    Galindo, Griselda
    Klinkhoff, Alice
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1156 - 1156
  • [10] Methotrexate Use at Infliximab Initiation and Impact on Treatment Outcomes: An Analysis from the Canadian Registry, BioTRAC
    Choquette, Denis
    Thorne, Carter
    Kelsall, John
    Zummer, Michel
    Starr, Michael
    Sheriff, Maqbool
    Bensen, William
    Chow, Andrew
    Baer, Philip
    Rampakakis, Emmanouil
    Sampalis, John
    Nantel, Francois
    Lehman, Allen
    Otawa, Susan
    Shawi, May
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1453 - 1453
12345